From the programs: The new era of Comparative Effectiveness Research (CER) raises a number of critical questions for health care, among them: What are the best strategies for disseminating CER findings to providers and patients? How will new findings help patients make informed decisions? Will new comparative studies shed more light on the diverse needs of patient subpopulations, or will they limit patient access to personalized treatments? Discuss these questions and more during this sessions.
Martin Zagari,Vice President, Global Health Economics Amgen
RT @ChristianeTrue: Zagari: in US, seems to be national aversion to evidence. Guidances have not been greeted warmly. #BIO2012
Background here from JAMA on CE “The Patient Protection and Affordable Care Act of 2010 created the Patient-Centered Outcomes Research Institute (PCORI) to fund and promote comparative clinical effectiveness research (CER) that will “assist patients, clinicians, purchasers, and policy-makers in making informed health decisions by advancing the quality and relevance of evidence concerning the manner in which diseases, disorders, and other health conditions can effectively and appropriately be prevented, diagnosed, treated, monitored, and managed through research and evidence synthesis.” Cite: Patient Protection and Affordable Care Act, Pub L No. 111-148, 124 Stat 727, §6301